Glycopyrrolate Articles
Sciele's drooling drug meets Ph III endpoints
22 September 2008
Sciele completes Ph III drool-drug trial
14 July 2008
Sciele Pharma begins enrollment in Ph II
16 April 2007
First Horizon's glycopyrrolate gets OD designation
26 June 2006
Horizon acquires Robinul and Robinul Forte from Wyeth-Ayerst
4 February 1999
Showing 1-6 of 6 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
